Patients were excluded if they were under 18 years of age, received anything other than etomidate, succinylcholine or rocuronium for RSI, or had missing data. Selection of paralytic agent was ...
Despite etomidate's hemodynamic benefits ... All patients received IV succinylcholine (1 mg/kg) immediately after the trial medication and continuous sedation with midazolam (0.1 mg/kg/hour ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback